TVTX Stock-Based Compensation
Travere Therapeutics Inc · Stock-Based Compensation
TVTX Stock-Based Compensation
Latest reported$60.66Mperiod ending
TVTX Stock-Based Comp ($0.00 → $60.66M)
Annual stock-based compensation
High-resolution chart · PNG
TVTX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 44,868,000 | |
| 36,913,000 | |
| 44,246,000 | |
| 38,143,000 | |
| 29,566,000 | |
| 23,614,000 | |
| 21,105,000 | |
| 19,774,000 | |
| 26,874,000 | |
| 29,102,000 | |
| 25,900,000 | |
| 15,900,456 | |
| 1,424,528 | |
| 17,562,850 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |